<DOC>
	<DOCNO>NCT01380574</DOCNO>
	<brief_summary>The purpose study investigate complication cardioversion acute ( &lt; 48 hour duration ) atrial fibrillation ( AF ) . Primary Outcome Measures : - Incidence predictor thromboembolic complication , especially stroke , death &lt; 31 day cardioversion acute AF Secondary Outcome Measures : - Number therapy non-responder early recurrence AF - Bleeding complication 31 day follow-up - Hemodynamic complication cardioversion Estimated Enrollment : 3000 case Study Start Date : Jun 2011 Estimated Study Completion Date : December 2011</brief_summary>
	<brief_title>Safety Cardioversion Acute Atrial Fibrillation</brief_title>
	<detailed_description>It common practice perform cardioversion acute ( &lt; 48 hour ) AF without anticoagulation . The new European guideline recommend anticoagulation start already cardioversion patient CHADS2VASC score indicate need long-term oral anticoagulation . The evidence behind guideline , however , scarce . In retrospective study collect data safety acute AF cardioversion emergency room two university hospital one secondary referral center year 2003-2010 . Inclusion criterion : All patient admit emergency room acute AF electrical pharmacological cardioversion attempt &lt; 48 beginning symptom .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>patient admit emergency room acute AF electrical pharmacological cardioversion attempt &lt; 48 begin symptom duration AF unknown &gt; 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>cardioversion</keyword>
	<keyword>stroke</keyword>
	<keyword>thromboembolism</keyword>
</DOC>